Kanako has about 10 years of experience in applied biotech research at a major electronics manufacturer. After that, she has been engaged in basic research work at drug discovery venture companies for over 8 years. While serving as a group leader of new compound development at NapaJen pharma, she joined RDiscovery in 2021.
She holds a PhD in the Graduate School of Humanities and Sciences from Ochanomizu University.